Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132640) titled 'Bolus injection of Tegilerdine fumarate versus sufentanil on perioperative safety and efficacy in patients undergoing hysteroscopic surgery: a randomized, controlled, double-blind clinical study' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hangzhou First People's Hospital
Condition:
None
Intervention:
SB group:Sufentanil
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: SB group:120;TB Group:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=336254
Publ...